CLOV vs CI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

CLOV

52.4
AI Score
VS
CLOV Wins

CI

40.8
AI Score

Investment Advisor Scores

CLOV

52score
Recommendation
HOLD

CI

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLOV CI Winner
Revenue 1.49B 140.16B CI
Net Income 55.34M 3.31B CI
Net Margin 3.7% 2.4% CLOV
Operating Income 55.34M 5.03B CI
ROE 14.7% 7.8% CLOV
ROA 7.7% 2.1% CLOV
Total Assets 720.33M 157.08B CI
Current Ratio 1.50 0.85 CLOV

Relative Price Performance (Last 90 Days)

CLOV 1M: +6.2% · 3M: -1.6% CI 1M: +1.2% · 3M: -4.8%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.4 · Price: $4.82

CI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.3 · Price: $280.76

Fundamentals Snapshot

Metric CLOV CI
Market Cap
Forward P/E 32.1 8.4
Trailing P/E 11.5
Revenue (TTM)
Revenue Growth 0.6% 0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% 0.0%
EPS -0.05 24.41
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.